a year ago
VIR
AnalystsPatrick TrucchioPatrick Trucchio's Stock Forecasts
AnalystsPatrick Trucchio
Analyst Ranking
Bottom 1%
#4193 out of 4227 analysts
Average Return
-19.8%
Win Rate
26%27 out of 103
Risk vs Reward
Poor
Good
Patrick Trucchio's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunocore Holdings PLCIMCR | +164.64% | $23.53 | $62.27 | 2022-02-07 - 2023-02-07 | Buy |
F Star Therapeutics IncFSTX | +79.30% | $3.43 | $6.15 | 2022-03-16 - 2022-07-15 | Buy |
Alnylam Pharmaceuticals IncALNY | +65.25% | $138.31 | $228.56 | 2022-01-19 - 2023-01-19 | Buy |
Longboard Pharmaceuticals IncLBPH | +55.94% | $4.88 | $7.61 | 2022-04-26 - 2023-04-26 | Buy |
Alnylam Pharmaceuticals IncALNY | +45.18% | $139.05 | $201.87 | 2022-05-01 - 2023-05-01 | Buy |
Patrick Trucchio Analyst Color
Get additional color on Patrick Trucchio's coverage of popular stocks
Patrick Trucchio's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Oncolytics Biotech IncONCY | 3 | Buy | $15.00 | +757.14% | Reiterates | 4 days ago |
Milestone Pharmaceuticals IncMIST | 6 | Buy | $25.00 | +528.14% | Reiterates | 7 days ago |
Silence Therapeutics PLCSLN | 5 | Buy | $80.00 | +1,298.60% | Reiterates | 13 days ago |
Altimmune IncALT | 6 | Buy | $50.00 | +1,122.49% | Reiterates | 15 days ago |
Invivyd IncIVVD | 2 | Buy | $5.00 | +248.43% | Reiterates | 15 days ago |
Homology Medicines IncFIXX | 3 | Buy | $20.00 | +1,860.78% | Reiterates | 15 days ago |
Compass Pathways PLCCMPS | 3 | Buy | $120.00 | +1,468.63% | Reiterates | 16 days ago |
Atai Life Sciences NvATAI | 4 | Buy | $20.00 | +1,029.94% | Reiterates | 16 days ago |
Gh Research PLCGHRS | 3 | Buy | $45.00 | +309.09% | Reiterates | 19 days ago |
Longboard Pharmaceuticals IncLBPH | 3 | Buy | $25.00 | +261.27% | Reiterates | 19 days ago |
Immunocore Holdings PLCIMCR | 6 | Buy | $90.00 | +57.34% | Reiterates | 19 days ago |
Gossamer Bio IncGOSS | 5 | Buy | $5.00 | +284.62% | Reiterates | 20 days ago |
Mind Medicine IncMNMD | 6 | Buy | $75.00 | +2,021.64% | Reiterates | 22 days ago |
Sangamo Therapeutics IncSGMO | 3 | Buy | $5.00 | +296.83% | Maintains | a month ago |
Alnylam Pharmaceuticals IncALNY | 8 | Buy | $415.00 | +120.44% | Reiterates | a month ago |
Freeline Therapeutics Holdings PLCFRLN | 4 | Buy | $30.00 | +1,100.00% | Maintains | 2 months ago |
Precision Biosciences IncDTIL | 2 | Buy | $17.00 | +2,200.41% | Reiterates | 3 months ago |
Cybin IncCYBN | 3 | Buy | $10.00 | +3,324.66% | Reiterates | 3 months ago |
Uniqure NvQURE | 2 | Buy | $90.00 | +362.72% | Reiterates | 3 months ago |
Vir Biotechnology IncVIR | 8 | Buy | $100.00 | +283.88% | Maintains | 3 months ago |
Reunion Neuroscience IncREUN | 3 | Buy | $20.00 | +2,757.14% | Reiterates | 3 months ago |
Arrowhead Pharmaceuticals IncARWR | 5 | Buy | $90.00 | +167.86% | Reiterates | 4 months ago |
Benitec Biopharma IncBNTC | 2 | Buy | $4.00 | +1,662.11% | Maintains | 8 months ago |
F Star Therapeutics IncFSTX | 4 | Hold | $7.00 | -1.69% | Downgrades | a year ago |
Arena Pharmaceuticals IncARNA | 2 | Hold | $100.00 | N/A | Downgrades | a year ago |
Allakos IncALLK | 2 | Buy | $20.00 | N/A | Maintains | a year ago |
Flexion Therapeutics IncFLXN | 2 | Hold | $10.00 | N/A | Downgrades | 2 years ago |
Mondaycom LtdMNDY | 1 | Buy | $340.00 | N/A | Maintains | 2 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.